Multi-faceted effects of positive incidents on stress system functioning in a patient with systemic lupus erythematosus

Stress and Health

Volumn 22, Issue 4, 2006, Pages 215-227

  Schubert, Christian ^a   Noisternig, Bianca ^a   Fuchs, Dietmar ^a   König, Paul ^a   Chamson, Emil ^a   Mittnik, Stefan ^b   Schüßler, Gerhard ^a   Geser, Willi ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cortisol; Neopterin; Positive incidents; Systemic lupus erythematosus; Time series analysis

Indexed keywords

ANTIINFLAMMATORY AGENT; HYDROCORTISONE; NEOPTERIN; STEROID;

ADULT; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMOTION; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERVIEW; LIFE EVENT; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME SERIES ANALYSIS; URINALYSIS;

EID: 33750503060     PISSN: 15323005     EISSN: 15322998     Source Type: Journal    
DOI: 10.1002/smi.1096     Document Type: Article

References (71)

1. Adams, D.O. (1994). Molecular biology of macrophage activation: A pathway whereby psychosocial factors can potentially affect health. Psychosomatic Medicine, 56, 316-327.
2. Adams, S.G., Dammers, P.M., Saia, T.L., Brantley, P.J., & Gaydos, G.R. (1994). Stress, depression, and anxiety predict average symptom severity and daily symptom fluctuation in systemic lupus erythematosus. Journal of Behavioral Medicine, 17, 459-477.
3. American Psychiatric Association (APA) (1994). Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Washington, DC: APA.
4. American Rheumatism Association Glossary Committee (1982). Dictionary of the rheumatic diseases, Vol I. New York: Contact Associates.
5. Bartels, A., & Zeki, S. (2000). The neural basis of romantic love. Neuroreport, 11, 3829-3834.
6. Becker, P. (1988). Skalen für Verlaufsstudien der emotionalen Befindlichkeit. Zeitschrift für experimentelle und angewandte Psychologie, 3, 345-369.
7. Besedovsky, H.O., & del Rey, A. (1991). Physiological implications of the immune-neuroendocrine network. In R. Ader, D.L. Felten, & N. Cohen (Eds), Psychoneuroimmunology 2nd ed. (pp. 589-608). San Diego, CA: Academic Press.
8. Box, G.E.P., & Jenkins, G.M. (1976). Time-series analysis: Forecasting and control. San Francisco, CA: Holden-Day.
9. Boyatzis, R.E. (1998). Transforming qualitative information. London: Sage Publications.
10. Braun, P.A., & Mittnik, S. (1993). Misspecifications in vector autoregressions and their effects on structural impulse responses and variance decompositions. Journal of Econometrics, 59, 319-341.
11. Brown, G.W., & Harris, T.O. (1989). Life events and illness (pp. 3-45). New York: Guilford Press.
12. Brown, W.A., Sirota, A.D., Niaura, R., & Engebretson, T.O. (1993). Endocrine correlates of sadness and elation. Psychosomatic Medicine, 55, 458-467.
13. Buchanan, T.W., al'Absi, M., & Lovallo, W.R. (1999). Corticol fluctuates with increases and decreases in negative affect. Psychoneuroendocrinology, 24, 227-241.
14. Cacioppo, J.T., & Gardner W.L. (1999). Emotion. Annual Review of Psychology, 50, 191-214.
15. Chrousos, G.P., & Gold, P.W. (1992). The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. Journal of the American Medical Association, 267, 1244-1252.
16. Cronbach, L.J. (1975). Beyond the two disciplines of scientific psychology. American Psychologist, 30, 116-127.
17. Davidson, R. (2000). Affective style, psychopathology, and resilience: Brain mechanisms and plasticity. American Psychologist, 55, 1196-1214.
18. Derdikman, D., Hildesheim, R., Ahissar, E., Arieli, A., & Grinvald, A. (2003). Imaging spatiotempotal dynamics of surround inhibition in the barrels somatosensory cortex. Journal of Neuroscience, 23, 3100-3105.
19. Dotevall, L., Fuchs, D., Reibnegger G., Wachter, H., & Hagberg, L. (1990). Cerebrospinal fluid and serum neopterin levels in patients with Lyme neuroborreliosis. Infection, 18, 210-214.
20. Ehlert, U., Gaab, J., & Heinrichs, M. (2001). Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: The role of the hypothalamus-pituitary-adrenal axis. Biological Psychology, 57, 141-152.
21. Epel, E.S., McEwen, B.S., & Ickovics, J.R. (1998). Embodying psychological thriving: Physical thriving in response to stress. The Journal of Social Issues, 54, 301-322.
22. Eriksen, H.R., Olff, M., Murison, R., & Ursin, H. (1999). The time dimension in stress responses: Relevance for survival and health. Psychiatry Research, 85, 39-50.
23. Folkman, S., & Moskowitz, J.T. (2000). Positive affect and the other side of coping. American Psychologist, 55, 647-654.
24. Frederickson, B.L., & Levenson, R.W. (1998). Positive emotions speed recovery from the cardiovascular sequelae of negative emotions. Cognition & Emotion, 12, 191-220.
25. Fuchs, D., Weiss, G., & Wachter, H. (1993). Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. International Archives of Allergy and Immunology, 101, 1-6.
26. Fuchs, D., Stahl-Hennig, C., Gruber, A., Murr, C., Hunsmann, G., & Wachter, H. (1994). Neopterin - its clinical use in urinalysis. Kidney International, 47(suppl.), S8-S11.
27. Futterman, A.D., Kemeny, M.E., Shapiro, D., & Fahey, J.L. (1994). Immunological and physiological changes associated with induced positive and negative mood. Psychosomatic Medicine, 56, 499-511.
28. Gutierrez, M.A., Garcia, M.E., Rodriguez, J.A., Rivero, S., & Jacobelli, S. (1998). Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus, 7, 404-408.
29. Hellhammer, D., Kirschbaum, C., & Lehnert, H. (1989). Zur Rolle der Hypophysen-Nebennierenrinden-Achse in Belastungssituationen. Homo, 39, 16-26.
30. Hu, Y., Dietrich, H., Herold, M., Heinrich, P.C., & Wick, G. (1993). Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. International Archives of Allergy and Immunology, 102, 232-241.
31. Hubert, W., & de Jong-Meyer, R. (1990). Psychophysiological response patterns to positive and negative film stimuli. Biological Psychology, 31, 73-93.
32. Hubert, W., & de Jong-Meyer, R. (1991). Autonomic, neuroendocrine, and subjective responses to emotion-inducing film stimuli. International Journal of Psychophysiology, 11, 131-140.
33. Jacobs, R., Pawlak, C.R., Mikeska, E., Meyer-Olson, D., Martin, M., Heijnen, C.J., Schedlowski, M., & Schmidt, R.E. (2001). Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology, 40, 868-875.
34. Jenkins, G.M., & Watts, D.W. (1969). Spectral analysis and its applications. San Francisco, CA: Holden-Day.
35. Knapp, P.H., Levy, E.M., Giorgi, R.G., Black, P.H., Fox, B.H., & Heeren, T.C. (1992). Short-term immunological effects of induced emotion. Psychosomatic Medicine, 54, 133-148.
36. Koolhaas, J.M., Meerlo, P., de Boer, S.F., Strubbe, J.H., & Bohus, B. (1997). The temporal dynamics of the stress response. Neuroscience & Biobehavioral Reviews, 21, 775-782.
37. Lane, R.D., Reiman, E.M., Ahern, G.L., Schwartz, G.E., & Davidson, R.J. (1997). Neuroanatomical correlates of happiness, sadness, and disgust. American Journal of Psychiatry, 154, 926-933.
38. Lazarus, R.S. (1991). Emotion and adaptation. Oxford: Oxford University Press.
39. Leohiron, J., Thuvasethakul, P., Sumethkul, V., Pholcharoen, T., & Boonpucknavig, V. (1991). Urinary neopterin in patients with systemic lupus erythematosus. Clinical Chemistry, 37, 47-50.
40. Lim, K.L., Muir, K., & Powell, R.J. (1994). Urine neopterin: A new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 53, 743-748.
41. Lim, K.L., Jones, A.C., Brown, N.S., & Powell, R.J. (1993). Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: Comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products. Annals of the Rheumatic Diseases, 52, 429-435.
42. Lincoln, Y.S., & Guba, E.G. (1985). Naturalistic inquiry. London: Sage Publications.
43. Ljung, G.M., & Box, G.E.P. (1978). On a measure of lack of fit in time series models. Biometrika, 65, 297-303.
44. Mason, J.W. (1968). A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosomatic Medicine, 30, 576-607.
45. Mathiesen, T., Fuchs, D., Wachter, H., & von Holst, H. (1990). Increased CSF neopterin levels in subarachnoid hemorrhage. Journal of Neurosurgery, 73, 69-71.
46. McEwen, B.S., Biron, C.A., Brunson, K.W., Bulloch, K., Chambers, W.H., Dhabhar, F.S., Goldfarb, R.H., Kitson, R.P., Miller, A.H., Spencer, R.L., & Weiss, J.M. (1997). The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions. Brain Research Reviews, 23, 79-133.
47. Mok, C.C., & Lau, C.S. (2003). Pathogenesis of systemic lupus erythematosus. Journal of Clinical Pathology, 56, 481-490.
48. Munck, A., Guyre, P.M., & Holbrook, N.J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Reviews, 5, 25-44.
49. Murr, C., Widner, B., Wirleitner, B., & Fuchs, D. (2002). Neopterin as a marker for immune system activation. Current Drug Metabolism, 3, 175-187.
50. Patton, M.Q. (2002). Qualitative research and evaluation methods. London: Sage Publications.
51. Pawlak, C.R., Witte, T., Heiken, H., Hundt, M., Schubert, J., Wiese, B., Bischoff-Renken, A., Gerber, K., Licht, B., Goebel, M.U., Heijnen, C.J., Schmidt, R.E., & Schedlowski, M. (2003). Flares in patients with systemic lupus erythematosus are associated with daily psychological stress. Psychotherapy and Psychosomatics, 72, 159-165.
52. Peralta-Ramirez, M.I., Jimenez-Alonso, J., Godoy-Garcia, J.F., Perez-Garcia, M., & Group Lupus Virgen de las Nieves (2004). The effects of daily stress and stressful life events on the clinical symptomatology of patients with lupus erythematosus. Psychosomatic Medicine, 66, 788-794.
53. Phan, K.L., Wager, T., Taylor, S.F., & Liberzon, I. (2002). Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. NeuroImage, 16, 331-348.
54. Post, M.R. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorders. American Journal of Psychiatry, 149, 999-1010.
55. Proust, M. (2003). In search of lost time (p. 245). New York: Penguin.
56. Reinsel, G.C. (1997). Elements of multivariate time series analysis. New York: Springer.
57. Rose, M.R. (1984). Overview of endocrinology of stress. In G.M. Brown, S.H. Koslow, & S. Reichlin (Eds), Neuroendocrinology and psychiatric disorder (pp. 95-122). New York: Raven Press.
58. Rothman, K.J. (1990). No adjustments are needed for multiple comparisons. Epidemiology, 1, 43-46.
59. Samsonov, M.Y., Tilz, G.P., Egorova, O., Reibnegger, G., Balabanova, R.M., Nassonov, E.L., Nassonova, V.A., Wachter, H., & Fuchs, D. (1995). Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus, 4, 29-32.
60. Schubert, C. (1998). Psychoneuroimmunologische Forschung im Kontext biochemischer Erkenntnisfortschritte: Paradigmatische Grenzen. Zeitschrift für Psychosomatische Medizin und Psychotherapie, 44, 1-20.
61. Schubert, C., Geser, W., Noisternig, B., König, P., Rumpold, G., & Lampe, A. (2002). Stressful life events and skin diseases: An additional perspective from research on psychosomatic dynamics in systemic lupus erythematosus. Psychotherapy and Psychosomatics, 71, 123-124.
62. Schubert, C., Lampe, A., Rumpold, G., Fuchs, D., König, P., Chamson, E., & Schüßler, G. (1999). Daily psychosocial stressors interfere with the dynamics of urine neopterin in a patient with systemic lupus erythematosus: An integrative single-case study. Psychosomatic Medicine, 61, 876-882.
63. Schubert, C., Lampe, A., Geser, W., Noisternig, B., Fuchs, D., König, P., Chamson, E., & Schuüßler, G. (2003). Daily psychosocial stressors and cyclic response patterns in urine cortisol and neopterin in a patient with systemic lupus erythematosus. Psychoneuroendocrinology, 28, 459-473.
64. Smyth, J., Ockenfels, M.C., Porter, L., Kirschbaum, C., Hellhammer, D.H., & Stone, A.A. (1998). Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. Psychoneuroendocrinology, 23, 353-370.
65. SPSS Inc. (1999). SPSS Trends™ 10.0. Chicago: SPSS Inc.
66. Stone, A.A., Marco, C.A., Cruise, C.E., Cox, D.S., & Neale, J.M. (1996). Are stress-induced immunological changes mediated by mood? A closer look at how both desirable and undesirable daily events influence sIgA antibody. International Journal of Behavioral Medicine, 3, 1-13.
67. Stone, A.A., Neale, J.M., Cox, D.S., Napoli, A., Valdimarsdottir, H., & Kennedy-Moore, E. (1994). Daily events are associated with a secretory immune response to an oral antigen in men. Health Psychology, 13, 440-446.
68. Turner, J.R., Ward, M.M., Gellman, M.D., Johnston, D.W., Light, K.C., & van Doornen, L.J.P. (1994). The relationship between laboratory and ambulatory cardiovascular activity: Current evidence and future directions. Annals of Behavioral Medicine, 16, 12-23.
69. Van Eck, M., Berkhof, M.S., Nicolson, N., & Sulon, J. (1996). The effects of perceived stress, traits, mood states, and stressful daily events on salivary cortisol. Psychosomatic Medicine, 58, 447-458.
70. Wachter, H., Fuchs, D., Hausen, A., Reibnegger, G., & Werner, E.R. (1989). Neopterin as marker for activation of cellular immunity: Immunologic basis and clinical application. Advances in Clinical Chemistry, 27, 81-141.
71. Zietz, B., Reber, T., Oertel, M., Glück, T., Schölmerich, J., & Straub, R. (2000). Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. The Journal of Rheumatology, 27, 911-918.